Nanoparticle Therapeutics 2016 - Making clinical translation a reality

23 Oct 2016 to 26 Oct 2016
Pullman Palm Cove Sea Temple Resport & Spa, QLD

Session topics:

  • Theranostics: combined diagnostics and therapies for disease detection and treatment.
  • Anti-cancer therapeutics and vaccines: Nanoparticles treatments for cancer from the laboratory to the clinic.
  • Natural Product Therapies: Investigating the properties of natural remedies in today's world.
  • Nanoparticle Safety: Regulatory requirements and testing.
  • Anti-viral therapeutics and vaccines: Nanoparticles treatments for existing and emerging viruses from the laboratory to the clinic.
  • Strategies targeting Antibiotic resistance: Saving antibiotics, combating the emerging prevalence of resistance.
  • RNAi and Drug delivery: New strategies for RNAi and repurposing of drugs for new applications.

The abstract submission deadline is Friday, 5 August 2016. Guidelines on how to write and submit your abstract are available.

Key dates:

  • 5 August 2016 - Earlybird registration and abstract submission deadline
  • 23 October 2016 - Conference Commences

Confirmed Speakers:     

  • Prof Russell Crawford - RMIT University
  • Dr Anne Field - Therapeutics Goods Administration
  • Dr Silke Krol - Insituto tumori "Giovanni Paolo II"
  • Dr Rashmi Pathak - Starpharma
  • Prof Stephen Rose - CSIRO
  • A/Prof Eveline Tiralongo - Griffith University
  • Prof Ralph Tripp - University of Georgia
  • Dr Alexander Zelinkin - Aarhus University
     

Nanoparticle Therapeutics conference website